Trials / Conditions / Leukemia, Chronic Myeloid

Leukemia, Chronic Myeloid

11 registered clinical trials studyying Leukemia, Chronic Myeloid.

Status	Trial	Sponsor	Phase
Completed	A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, NCT07151820	Novartis Pharmaceuticals	—
Completed	Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment NCT07188428	Novartis Pharmaceuticals	—
Completed	The EMPATHY Pilot Study NCT04384848	Northwestern University	N/A
Unknown	Evaluation of the Therapeutic Effect of HU Pulse Therapy for CML Patients NCT03515018	First Affiliated Hospital of Harbin Medical University	Phase 3
Withdrawn	A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML NCT02973711	University of Michigan Rogel Cancer Center	Phase 1 / Phase 2
Completed	Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response NCT02852486	University of Campinas, Brazil	Phase 2
Terminated	Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT NCT02627573	St. Petersburg State Pavlov Medical University	Phase 2
Completed	Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response NCT02326311	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia	Phase 3
Unknown	Multicenter, PhaseⅣ, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positiv NCT02389920	Samsung Medical Center	Phase 4
Unknown	Malaysia Stop Tyrosine Kinase Inhibitor Trial NCT02381379	Ministry of Health, Malaysia	Phase 3
Terminated	Chronic Myelod Leukemia Registry at Asan Medical Center NCT01761695	Asan Medical Center	—